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AbSTRACT
 This study describes the qualitative phytochemical screening, antimicrobial and GC-MS 
analyses of the crude methanol extract of the stem and roots parts of Bidens pilosa partitioned 
between methanol, dichloromethane, ethyl acetate and hexane solvents. Phytochemical analysis 
indicated the presence of cardiac glycosides, terpenoids, flavonoids and alkaloids. Saponins were 
not found in any of the fractions of stem and root of B. pilosa. Antibacterial studies indicated that the 
lowest concentration (6.25 mg/mL) was achieved for Candida subtilis for the ethyl acetate fraction 
of the stem extract and hexane fraction of the root extract. Antimycobacterial test activity of these 
solvent fractions revealed that the hexane fraction of the root extract was susceptible to the bacterium 
isolate. Gas chromatography-Mass spectrometric study revealed the presence of the following 
compounds-cis-9-Hexadecenal, 2-hydroxyl ethyl (Z)-9-Octadecenoate, Octadecanal, Oleic acid, 
4-(dimethylamino)-Benzaldehyde, 4,6,7-Trimethoxy-2,3-dihydrofuro(2,3-b)quinolone.
keywords: Bidens pilosa, Antibacterial studies, Medicinal plants, Phytochemicals, Antimicrobial, 
Anti-mycobacterial, Gas chromatography-mass spectrometry.
INTROdUCTION
 The application of modern medicine in 
the treatment of diverse infections has involved 
the prescription and administration of antibiotics. 
However, there has been reported side effects 
accompanying the use of antibiotics, such as: 
nausea, diarrhea, headache and rashes1. Moreover, 
use of adulterated drugs, overuse and incomplete 
use of prescribed medications have resulted in 
increasing rate of drug resistant antibiotics. This has 
led to increased interest in the use of medicinal plants 
as probable candidates for less toxic antimicrobials. 
The practice of medicinal plants symbolizes the 
ancient and most extensive form of medication that 
have been employed from time immemorial. Most 
natural medications obtained directly from plant or 
animal have been applied either as a preventive 
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or curative means to maintain the human health 
system. Efforts made towards meeting the basic 
health care needs of the population, included the use 
of traditional medicine, which is widely practiced in 
many developing countries2. The therapeutic effects 
inherent in plants is attributed to the availability 
of some phytochemicals produced by plants. 
Some of the metabolites synthesized during the 
developmental stages of plants include phenolics, 
terpenoids, amines, alkaloids, glycosides and 
protein amino acids3. B. pilosa is a widely distributed 
herb that can be easily cultivated. Sometimes, it 
is considered a weed as a result of its abundant 
propensities. Reports on the application of B. pilosa 
has covered over 40 ailments. In India and Africa, 
the leaf part of B. pilosa is used as decoction to treat 
stomach disorders. Whole plant is used as decoction 
in Uganda, Cuba and China to treat diarrhea and 
asthma4, In China, the root part is used to treat 
malaria5. Previous studies on this plant identified 
some of its biological properties which includes: 
antibacterial6, antimalarial5, anti-inflammatory7 and 
antioxidant8. Phytochemical and pharmacological 
activities employing the B. pilosa leaves9-10, roots11, 
the stem12 and aerial parts13 have been published. 
A recent study carried out leaf, stem and root of this 
plant from six different locations14. In that study the 
authors observed that the bioactive composition of 
the extracts was dependent on the location where 
the plant was cultivated and concluded that the leaf 
parts exhibited highest antioxidant activity, followed 
by the root parts, while the stem exhibited the least 
activity. In another study on the antibacterial activity 
of the aqueous fractions of the leaf, stem and root of 
the plant;10 the authors concluded that the aqueous 
fraction of the leaf was more biologically active 
against bacteria. Earlier work on this plant on the 
in-vitro  antibacter ial,  phytochemical, anti-
mycobacterial and GC-MS analyses of B. pilosa leaf 
extract has been published9. The aim of this study is 
to evaluate the antimicrobial activity of the fractions 
and identify from GC-MS analysis the components of 
stem and root extracts of B. pilosa linn. The present 
study is to carry out a comparative analysis of the 
stem and root part of this plant with the previous work 
reported on the leaf extract of B. pilosa and also to 
validate the ethnobotanical claim of the application 
of this plant in the treatment of infectious disease 
such as tuberculosis.
MATERIALS ANd METHOdS  
Collection of Stem and Root parts of Bidens pilosa 
 Plant samples of B. pilosa were locally 
sourced within Ado-Odo Ota of Ogun state, at 
location of 6o 41′ N 3o 41′. Forest Research Institute 
of Nigeria, authenticated the plant samples with a 
voucher number FHI 110016. Clean water was used 
to thoroughly wash the stem and root samples of 
B. pilosa. Washed samples were air-dried for three 
weeks. Thereafter, samples were crushed into 
smaller particles using a milling machine.
Extraction of the stem and root parts of Bidens pilosa
 At a temperature of 29OC, cold maceration 
of the stem and root parts of B. pilosa was carried 
out for 72 h with methanol, employed for solvent 
extraction. The extract obtained was partitioned into: 
hexane, dichloromethane, ethyl acetate, methanol 
fractions.
phytochemical screening of the stem and root 
extracts of B. pilosa
 Standard qualitative methods was used to 
ascertain the presence of secondary metabolites in 
the stem and root parts of B. pilosa. 
Test for Carbohydrates
 Molisch’s reagent (1 mL), was added to 2 mL 
of plant extracts. Few drops of concentrated sulphuric 
acid was added to the mixture. Carbohydrate is 
confirmed by the formation of purple colour.
Test for Tannins
 2 mL of 5% ferric chloride was added to 
1 mL of plant extracts. Greenish black colour 
indicated the presence of tannins.
Test for Saponins
 2 mL of distilled water was added to 2 mL 
of plant extracts and shaken in a graduated cylinder 
for 15 minutes lengthwise. Presence of saponins is 
shown by the formation of 1cm layer of foam.
Test for Flavonoids
 To 1 mL of the aqueous filtrate of plant 
extracts was added 5 mL of dilute ammonia solution 
followed by addition of concentrated sulphuric acid. 
Flavonoids is indicated by the appearance of yellow 
coloration.
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Test for Alkaloids
 2 mL of concentrated hydrochloric acid was 
added to 2 mL of plant extracts; to which few drops of 
Mayer’s reagent was added. Alkaloids are indicated 
by the formation of green colour.
Test for Anthocyanin and betacyanin
 1 mL of 2 M sodium hydroxide was added to 
2 mL of plant extracts and heated for 5 min at 100OC. 
Yellow colour is formed; indicating the presence of 
betacyanin.
Test for Quinones
 Concentrated sulphuric acid (1 mL), was 
added to 1 mL of plant extracts. Red colour is formed; 
indicating the presence of quinones.
Test for Glycosides
 Addition of 3 mL of chloroform and 10% 
ammonia solution to 2 mL of plant extracts resulted 
in pink colour formation. Presence of glycosides is 
indicated.
Test for Cardiac glycosides
 2 mL of glacial acetic acid and few drops 
of 5% ferric chloride were added to 0.5 mL of plant 
extracts. To this mixture, 1 mL of concentrated 
sulphuric acid was added. Formation of brown ring 
at the interface showed that cardiac glycosides is 
present.
Test for Terpenoids
 2ml of chloroform was added to 0.5 mL of 
plant extracts and concentrated sulphuric acid was 
carefully added. Formation of red brown colour at 
the interface indicated the presence of terpenoids.
Test for Triterpenoids
 1 mL of Libermann–Buchard Reagent 
(acetic anhydride + concentrated sulphuric acid) was 
added to 1.5 mL of plant extracts. Blue green colour 
is formed; indicating the presence of triterpenoids. 
Test for Phenols 2 mL of distilled water was added 
to 1mL of the plant extracts followed by few drops 
of 10% ferric chloride. Green colour is formed, 
indicating the presence of phenols.
Test for Coumarins
 1ml of 10% Sodium hydroxide was added 
to 1 mL of plant extracts. Yellow colour is formed, 
indicating the presence of coumarins.
Test for steroids
 Chloroform (5 mL) was added to 2 mL of 
the extracts and filtered. 2 mL of acetic anhydride 
was added to 2 mL of filtrate with 2 mL of sulphuric 
acid. Change of colour from violet to blue or green 
indicates the presence of steroids.
Test for Acids
 Sodium bicarbonate solution was added to 
1 mL of extracts. Presence of acids is indicated by 
the formation of effervescence.
Antibacterial activity of Bidens pilosa stem and 
root extracts
 Antibacterial activity against Candida 
albicans, Rhizopus, Pseudomonas aeruginosa, 
Serratia spp, Micrococcus varians, Staphylococcus 
aureus, Escherichia coli, Bacillus spp was carried out 
using extracts of the stem and root parts of B. pilosa. 
Medium used for these isolates was Sabouraud 
dextrose agar.
Minimum Inhibitory Concentration (MIC) 
determination
 Minimum inhibitory concentration of the 
stem extracts and root extracts of B. pilosa using 
microplate dilution method8 was employed against test 
isolates: Candida albicans, Rhizopus, Pseudomonas 
aeruginosa, Bacillus subtilis, Escherichia coli, 
Klebsiella pneumonia and   Staphylococcus aureus, 
Concentrations of the extracts were reformed to 
50, 25, 12.5, 6.25, 3.125 and 1.562 mg/mL. Control 
used as standard antibiotics was gentamycin 
having a concentration of 10 µg. Test organisms 
of 0.5% McFarland standard were seeded on a 
sterile nutrient agar plates. Wells of about 9 mm 
in diameter was bored into the agar plate using a 
sterile cork borer.  0.2 mL of each extract of different 
concentrations was inoculated into the bored wells. 
After incubation at 37OC for 24 h, observations were 
made for growth and death of test organisms.
Anti-mycobacterial susceptibility test
 Anti-mycobacterial susceptibility test, 
using the proportion method on an L-J medium 
was employed using standard procedures. 
Standard chemicals were procured to prepare 
the mycobacterium tuberculosis isolates. The 
isolates were introduced in-vitro against stem 
and root extracts/fractions of B. pilosa, rifampicin 
(drug susceptible) at a concentration of 40 µg and 
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levofloxacin (drug resistant) at a concentration of 200 
µg on an L-J medium. Thereafter, incubation took 
place at a temperature of 37OC. After the 28th and 
42nd day, readings were taken in quintuples for drug 
susceptible and duplicates for drug resistance. Mean 
reduction in number of colonies on test samples 
when compared to drug-free controls was employed 
in evaluating the percentage resistance in the L-J 
medium. 
Quantitative phytochemical evaluation
 Phenols 0.8 ml of Folin-Ciocalteu’s reagent 
was added to 0.2 mL of sample in a test tube. 2 mL of 
7.5% Na2CO3 was added and mixed. Distilled water 
(7 mL) was added; after which it was incubated in the 
dark for 2 hour. Absorbance was taken at 765 nm.
Flavonoid
 To 0.5 mL of each extract solution was 
added 2.5 mL of 95% ethanol. To this mixture was 
added 0.1 mL of 1 M potassium acetate, 2.8 mL 
distilled water and 0.1 mL of 10% (AlCl3).6H2O. At 
room temperature, mixture was incubated for 45 min; 
after which absorbance was taken at 415 nm.
Steroid
 Sulphuric acid (4 N, 2 mL) and iron(III) 
chloride (0.5% w/v, 2 mL), were added to 1 mL of 
each extract. To this mixture was added potassium 
hexacyanoferrate(III) solution (0.5% w/v, 0.5 mL). 
In a water bath, the mixture is kept at 70OC for 
30 min with constant shaking; after which absorbance 
is taken at 780 nm.
Alkaloid
 100 mL of ethanolic acetic acid was added 
to 2.5 g of the sample into a 250 mL beaker. Mixture 
is allowed to incubate for 4 hours. It is filtered 
and heated to one-quarter of its original volume. 
Ammonium hydroxide solution was added in drops 
until precipitation is complete. Collected precipitate 
was washed with dilute ammonia solution; after 
which it was filtered, dried and weighed.
GC-MS analysis of Bidens pilosa stem and root 
extracts
 The combined gas chromatography and 
mass spectrometry analysis was carried out on 
the stem extracts as well as root extracts of the B. 
pilosa plant; using Agilent equipment 7890A, with 
software by Mass Hunter to identify the volatile 
compounds from the plant parts. The equipment 
consists of inert capillary tube having a dimension 
of 30 mm × 0.25 mm ID × 0.25 µm film; a carrier 
gas of Helium flowing at 1.0 mL/min. At 250°C, the 
injector was operated; while the temperature of the 
oven was increased gradually from 50°C to 300°C 
for 10 minute. The NIST library data was employed 




 Table 1 shows the presence of secondary 
metabolites in the stem extracts of B. pilosa, which 
include tannins, alkaloids, cardiac glycosides, 
terpenoids, phenols, coumarins and steroids. In all 
the solvent fractions, terpenoids, cardiac glycosides 
and alkaloids were found present. Saponins were 
absent from all the solvent fractions. This is in 
contrast to previous studies. This may be due 
to difference in ecological factors. Flavonoids, 
carbohydrates were observed to be present in the 
hexane fraction and methanolic fraction. The ethyl 
acetate fractions as well as dichloromethane fraction 
showed the presence of phenols and tannins. All 
the solvents used in this study were of different 
polarities so as to identify the best solvents for 
extracting secondary metabolites from B. pilosa. 
Table 2 shows the phytochemicals in the root of 
B. pilosa. Saponins was absent from all the solvent 
fractions in root extracts. Steroids are absent in the 
methanolic fraction. However, the hexane, DCM and 
ethyl acetate fractions indicated the presence of 
steroids. Alkaloids, cardiac glycosides, terpenoids 
are found in all the solvent fractions of the root 
extract of B. pilosa.
 Table 3 shows the total tannin, flavonoids, 
a l ka lo ids  and  pheno ls  as  con ta ined  in 
dichloromethane, hexane, methanol and ethyl 
acetate fractions of the stem of B. pilosa. Ethyl 
acetate fraction contains more of the total steroids 
and total phenols, while the DCM fraction contains 
more of the total tannins. Total flavonoids is more 
abundant in the hexane fraction while the methanol 
fraction contains more of the total alkaloids. In Table 
4, the total tannin and total phenol is well indicated 
in the ethyl acetate fraction. Total flavonoids can be 
found more prominent in the hexane fraction of the 
root part of B. pilosa. Total alkaloids are well indicated 
in the methanolic fractions while the total steroids 
are more abundant in the hexane fraction.
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Table 1: Stem fractions of B. pilosa Showing Intensities of phytochemicals present
  Intensity
Constituents Hexane Dichloromethane Ethyl Acetate Methanol
 Fraction Fraction Fraction Fraction
Carbohydrates ++ - - ++
Tannins - ++ ++ ++
Saponins - - - -
Flavonoids ++ - - ++
Alkaloids ++ ++ ++ +
Anthocyanin & Betacyanin ++ - - -
Quinones ++ - - +
Glycosides - - - ++
Cardiac glycoside ++ ++ ++ ++
Terpenoids ++ + ++ ++
Triterpenoids ++ ++ ++ -
Phenols - + ++ -
Coumarins ++ + - -
Steroids ++ ++ ++ -
Acids - - - -
kEY:  + = trace,  ++ = moderate,    +++ = intense,     - = not present
Table 2: Root fractions of B. pilosa with intensities of Secondary metabolites present 
  Intensity
Constituents Hexane  Dichloromethane  Ethyl Acetate  Methanol 
 Fraction Fraction Fraction Fraction
Carbohydrates + - - +
Tannins - + + +
Saponins - - - -
Flavonoids + - - +
Alkaloids + + + +
Anthocyanin & Betacyanin + - - -
Quinones + + - +
Glycosides - - - +
Cardiac glycoside + + + +
Terpenoids + + + +
Triterpenoids + + + -
Phenols - + + -
Coumarins + + - -
Steroids + + + -
Acids - - - -
kEY:  + = trace,  ++ = moderate,    +++ = intense,     - = not present
Table 3: B. pilosa stem extract Showing Quantitative phytochemical Analysis
Fractions TotalAlkaloid (%) Total Flavonoid (%) Total Phenol    (%) Total Tannin (%) Total Steroids (%)
Hexane 0.32 0.42 - - 0.22
DCM 0.20 0.20 0.24 0.64 -
Ethyl acetate - - 0.32 0.36 0.35
Methanol 0.36 0.23 - 0.42 -
Table 4: B. pilosa root extract Showing Quantitative phytochemical Analysis  
Fractions Total Alkaloid (%) Total Flavonoid (%) Total Phenol (%) Total Tannin (%) Total Steroids (%)
Hexane 0.12 0.35 - - 0.17
DCM 0.08 - 0.13 0.05 -
Ethyl acetate - - 0.20 0.29 0.06
Methanol 0.24 0.23 - 0.02 -
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Antimicrobial analysis of stem and root fractions 
of Bidens pilosa
 Table 5 shows the stem por tion of 
B. pilosa, where the methanolic fraction shows 
activity against Bacillus subtilis. Dichloromethane, 
ethyl acetate and methanol fractions all indicated 
activity against Candida albicans. Table 6 indicates 
that the methanolic fraction of the root part of 
B. pilosa showed activity against Bacillus subtilis. 
All the solvents exhibited activity against Candida 
albicans. The hexane fraction showed activity against 
Rhizopus. From Table 7, the evaluation of antimicrobial 
in the stem of B. pilosa revealed the activities of 
methanol, dichloromethane and ethyl acetate against 
Candida albicans with the ethyl acetate fraction 
showing the lowest concentration against Candida 
albicans at 6.25 mg/L. From the same table, the 
hexane fraction of the root part of B. pilosa, showed 
the minimum concentration at 6.25 mg/L against 
Candida albicans. From Table 8, the evaluation of 
the antimicrobial in the root of B. pilosa indicated the 
activity of ethyl acetate and hexane fractions against 
Candida albicans. The hexane fraction shows more 
activity against Candida albicans at 6.25 mg/L.
Table 5: Stem fractions of B. pilosa Showing Zones of inhibition (in mm) against selected 
microorganisms
   Zone of inhibition in millimetres
Organism Hexane Dichloromethane Ethyl acetate Methanol Control
 fraction fraction fraction fraction (Gentamycin)
Bacillus subtilis  - 12 - 18 15
Escherichia coli  - - - - 8
Klebsiella pneumoniae 10 - 15 - 16
Pseudomonas aeruginosa - - - - 10
Staphylococcus aureus - - - - 8
Candida albicans  40 41 38 8
Rhizopus - - - - -
Table 6: Root fractions of B. pilosa Showing Zones of inhibition (in mm) against selected 
microorganisms
Organisms                            Zone of inhibition in millimetres
 Hexane Dichloromethane Ethyl acetate Methanol  Control
 fraction fraction fraction fraction (Gentamycin) 
Bacillus subtilis  - - 11 18 12
Escherichia coli  - - 11 - 11
Klebsiella pneumoniae - - - - -
Pseudomonas aeruginosa - - 10 - -
Staphylococcus aureus - - 13 - -
Candida albicans 40 12 38 38 8
Rhizopus 25 - - - 18
Table 7: Minimum Inhibitory Concentration of Stem Fractions of bidens pilosa for Selected Microorganism
Organisms Methanol Fraction(mg/ mL) Dichloromethane Fraction(mg/ mL) Ethyl acetate Fraction(mg/ mL)
Candida albicans 12.5 12.5 6.25
Table 8: Minimum Inhibitory Concentration of Root Fractions of bidens 
pilosa for Selected Microorganism
Organisms Ethyl acetate Fraction (mg/ mL) Hexane fraction (mg/ mL)
 
Candida albicans 12.5 6.25
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Antimycobacterial analysis of stem and root 
fractions of Bidens Pilosa
 Table 9 shows the results obtained from 
the in-vitro anti-mycobacterial analysis of the 
stem and root parts of B. pilosa plant using the 
proportion method. The crude, hexane, methanol 
and chloroform fractions of the stem part of 
B. pilosa indicated resistance to the anti-mycobacterial 
test; while only the hexane fraction of the root part 
indicated sensitivity against the test organism. 
Controls on the in-vitro analysis are 40 µg of 
drug susceptible (Rifampicin) and 200 µg of drug 
resistant (Levofloxacin). Where DS-MTB represent 
the drug susceptible mycobacterium tuberculosis, 
while DR-MTB in the table represent drug resistant 
mycobacterium tuberculosis. 
Table 9: Stem extract and Root extract of bidens pilosa against Mycobacterium tuberculosis isolate 
showing the availability of strains (resistant and sensitive)
Bidens pilosa Fractions DS-MTB 1 DS-MTB 2 DS-MTB 3 DS-MTB 4 DS-MTB 5 DR-MTB 1 DR-MTB 2 H37Rv
Stem Crude extract S R R R R R R S
 Chloroform  R S S R R R R R
 Methanolic  R R R R R R R R
 Hexane  R R R R R R R R
Root Crude extract R R R R R R R R
 Chloroform  R R R R R R R R
 Methanolic  R R R R R R R R
 Hexane  S S S S S S S S
key: S – Sensitive; R – Resistance
 Figure 1 illustrates the presence of various 
components of the stem of B. pilosa with different 
retention times. The nature and structure of the 
compounds are analyzed by the mass spectrometer 
as the compounds are eluted at different times. 
From Table 9, compounds identified by the GC-MS 
analysis for the stem part of B. pilosa include; cis-9-
Hexadecenal, 2-hydroxyl ethyl (Z)-9-Octadecenoate, 
Octadecanal and Oleic acid. Fig. 2 shows the 
presence of various components of the root of 
B. pilosa with different retention times. Some of the 
compound from the root part of B. pilosa by GC-MS 
analysis includes: 4-(dimethylamino)-Benzaldehyde, 
4,6,7-trimethoxy-2,3-dihydrofuro(2,3-b)quinolone. 
Fig. 1. Chromatogram of methanolic extract of B. pilosa Stem
Fig. 2 Chromatogram of methanolic extract of root of 
Bidens pilosa 
Fig. 3. Structures of Compounds Identified by GC-MS
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Table 10: Gas Chromatography-Mass spectrometry analysis of methanolic extract of 
stem of Bidens pilosa 
S/n Ret. time Compounds Molecular weight (g/mol) Molecular formula 
1. 1.19 cis-9-Hexadecenal 238.415 C16H30O
2. 34.332 2-hydroxylethyl(Z)-9-Octadecenoate 326.513 C20H38O3
3. 36.501 Octadecanal 268.478 C18H36O
4. 43.230 Oleic Acid 282.255 C18H34O2 
Table 11: Gas Chromatography-Mass spectrometry analysis of methanolic root extract of bidens pilosa
S/N Ret. time Compounds Molecular weight (g/mol) Molecular formula 
  1. 20.187 4-(dimethylamino)-Benzaldehyde 149.190 C9H11NO 
  2. 28.713 4,6,7-Trimethoxy-2,3-dihydrofuro(2,3-b)quinoline 261.277 C14H15NO4
dISCUSSION
 The presence of the following secondary 
metabolites was indicated in the stem and root 
extracts of B. pilosa: flavonoids, alkaloids, terpenoids, 
phenols, glycosides and tannins. This is confirmed 
by previous studies15. Cardiac glycoside compounds, 
though produced in small amounts in plants, are 
generally useful in the treatment of congestive heart 
failure. Cardiac glycosides in the stem and root parts 
of B. pilosa, could be the factor that explains its use 
in folk medicine as an antihypertensive agent and 
smooth muscle relaxant; with studies now confirming 
its efficacy16.
 Alkaloids are commonly distributed in 
plants and play a significant role in the defence 
systems against pathogens and animals. Medicinally, 
they are known as stimulants, local anesthetics, 
anti-bacterial, anti-hypertensive and analgesics. 
This explains the use of B. pilosa in the treatment 
of headaches and pains17.
 Flavonoids are a group of natural metabolites 
which can be found in several parts of a plant such 
as flowers, leaves, stem or root. They are responsible 
for the colour and aroma of flowers and fruits so as 
to attract pollinators resulting in dispersion of fruits 
and seeds for growth and development of seedlings. 
Consisting of diverse phenolic structures, flavonoids 
are made up of several subgroups, which include 
flavones, Chalcones, isoflavones and flavonols. 
They are known to contain wide spectrum of health 
promoting effects ranging from anti-inflammatory, 
anti-oxidative, anti-mutagenic, anti-carcinogenic to 
anti-viral and vasodilating actions. The presence of 
flavonoids in the stem and root parts of B. pilosa 
validates its traditional use to treat malaria, wounds, 
colds and flu18.
 Tables 2 and 3, reveal the quantitative 
phytochemicals present in the stem and root parts of 
B. pilosa. The table reveals hexane as a good solvent 
suitable for the extraction of flavonoids from the stem 
and root part of B. pilosa. For the total alkaloids, 
hexane and methanol solvents gave a high yield in 
the stem part of the plant; while methanol solvent is 
more suitable for extraction of high yield of alkaloids 
from the root part of B. pilosa. For a high yield of 
phenols from both stem and root, ethyl acetate is a 
very suitable solvent for extraction.
 The antimicrobial analysis of the stem of 
B. pilosa showed that only the methanol and ethyl 
acetate solvents of the stem showed activity against 
B. subtilis and K. pneumonia. The ethyl acetate 
solvent of the root parts showed higher activities 
against both the Gram-positive and Gram-negative 
bacteria strains than other solvents. This is in 
contrast with previous study11 on the antimicrobial 
studies on the root parts of a South African 
eco-type of B. pilosa. This may be as a result of 
different ecological environments of the plants under 
study. Earlier study of the leaf part of B. pilosa9, 
however, revealed methanol solvent as having 
higher activity against the bacteria strains more 
than the other solvents employed. This result aligns 
with earlier work carried out, where the whole plant 
extracts inhibited the growth of both Gram-positive 
and Gram-negative bacteria19.
 The ethyl acetate extracts from the stem 
part of B. pilosa showed higher activity against 
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Candida albicans at 6.25 mg/mL; the hexane extract 
of the root part of B .pilosa exhibited activity against 
Candida albicans at same concentration. Earlier 
study on the leaf part of B. pilosa, showed activity 
against Candida albicans from the methanol extract 
also at 6.25 mg/mL and from dichloromethane at 
3.125 mg/mL. All the solvent extracts from the stem 
part of the plant did not show any activity against 
Rhizopus; while the hexane extract from the root 
part showed a high activity compared to the control 
at 25 mm. This study is in compliance with a similar 
study on the root extracts from B. pilosa from South 
African ecotype11 which showed a moderate activity 
against Candida albicans. 
 Results obtained from the anti-mycobacterial 
analysis of the stem and root parts of B. pilosa using 
the proportion method revealed that the hexane 
fraction of the root part of B. pilosa shows sensitivity 
against the mycobacteria isolates while the stem 
parts showed resistance. This result complements 
findings from earlier study on the anti-mycobacterial 
activity of the leaf of B. pilosa9. Some studies on 
medicinal plants considered for treatment against 
infectious diseases such as tuberculosis by 
traditional medicine in South Africa20  was reported. 
From this study, B. pilosa was listed among several 
plants that has been applied locally in the treatment 
of tuberculosis, by adding water to the air-dried leaf, 
which is boiled for 45 min and taken orally daily for 
three weeks. 
 From Table 10, compounds identified by 
the gas-column spectroscopy indicate the presence 
of unsaturated fatty acids in the plant under study; 
which improves the blood lipid profile and reduces 
cardiovascular related issues21. In Table 11, the 
presence of 4-(dimethylamino)-Benzaldehyde and 
4,6,7-Trimethoxy-2,3-dihydrofuro(2,3-b)quinolone22 
with were also identified as shown in Fig. 3. 
Presence of quinolone derivative could relate to the 
anti-malaria property of the root part of the plant. 
This study has been able to validate the employment 
of this medicinal plant and also throw more light on 
the bioactive parts of the plant. The formula, name, 
molecular weight and structure of compounds 
identified by gas column mass spectrometry analysis 
were determined by comparing with the spectra 
of components stored in the database of National 
Institute Standard and Technology library. 
CONCLUSION
 Preliminary phytochemical analysis has 
identified cardiac glycosides, alkaloids, flavonoids 
existing within the stem and root parts of B. pilosa. 
The presence of these phytochemicals in the plant 
under study, have been responsible for its therapeutic 
properties; such as anti-malaria, analgesic, anti-
inflammatory, anti-hypertensive and the anti-oxidant 
activities of the medicinal plant. The plant, B. pilosa, 
from this present study shows its activity against 
Gram-positive and Gram-negative bacteria as well 
as against fungi. This validates the antibacterial 
and antifungal properties of B. pilosa as it is widely 
applied locally in the treatment of wounds, urinary 
tract infections, cough, respiratory tract infections 
or stomach ulcers. The in-vitro anti-mycobacterial 
analysis revealed the hexane fraction of the root part 
as being the bioactive part of the plant under study; 
while the stem part is shown to be inactive.
Significance statement
 This study confirmed the antibacterial 
and antifungal properties of B. pilosa, particularly 
the West African eco-type. It also established the 
antimycobacterial activity of the root part of the plant; 
thereby affirming its potency in its application to treat 
respiratory tract infections such as tuberculosis. The 
study contributes to the arsenal of potential drugs in 
combating drug resistant bacteria.
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